Howton David T Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$40.99M

Insider Activity of Howton David T

According to the SEC Form 4 filings, Howton David T, being in a position of

  1. Chief Operating Officer at Solid Biosciences Inc.,
    оver the last 12 months, has bought 0 shares, and sold 69066 shares for $433,538,
    over all time since 2023-12-04, has bought 0 shares, and sold 85066 shares for $498,876.

Biography of Howton David T

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $433,5384100

Comparison of Insiders on Amount of Buys and Sells

2026-02-18SaleSolid Biosciences Inc.
SLDB
Chief Operating Officer
7,469
0.0094%
$5.82$43,494+29.73%
2026-02-04SaleSolid Biosciences Inc.
SLDB
Chief Operating Officer
18,894
0.024%
$6.44$121,713+14.72%
2026-02-02SaleSolid Biosciences Inc.
SLDB
Chief Operating Officer
37,771
0.0485%
$6.44$243,128+16.1%
2025-12-03SaleSolid Biosciences Inc.
SLDB
Chief Operating Officer
4,932
0.0062%
$5.11$25,203+37.76%
2025-02-14SaleSolid Biosciences Inc.
SLDB
Chief Operating Officer
5,561
0.014%
$3.96$22,022+33.75%
2024-12-03SaleSolid Biosciences Inc.
SLDB
Chief Operating Officer
5,072
0.0136%
$5.60$28,396-6.47%
2023-12-04SaleSolid Biosciences Inc.
SLDB
Chief Operating Officer
5,367
0.0211%
$2.78$14,920+128.2%
2020-06-22SaleSarepta Therapeutics, Inc.
SRPT
EVP, General Counsel
105,122
0.1342%
$170.88$17.96M-21.6%
2019-12-13SaleSarepta Therapeutics, Inc.
SRPT
EVP, General Counsel
78,000
0.097%
$125.50$9.79M+4.3%
2019-11-22SaleSarepta Therapeutics, Inc.
SRPT
EVP, General Counsel
25,000
0.0321%
$105.00$2.63M+25.6%
2019-02-01SaleSarepta Therapeutics, Inc.
SRPT
SVP, General Counsel
30,000
0.0419%
$140.00$4.2M-13.46%
2018-07-16SaleSarepta Therapeutics, Inc.
SRPT
SVP, General Counsel
40,944
0.0575%
$127.18$5.21M-8.11%
2017-07-20SaleSarepta Therapeutics, Inc.
SRPT
SVP, General Counsel
5,944
0.0097%
$41.00$243,704+46.25%
2016-09-22SaleSarepta Therapeutics, Inc.
SRPT
SVP, General Counsel
7,000
0.0143%
$60.00$420,000-43.78%
2016-09-19SaleSarepta Therapeutics, Inc.
SRPT
SVP, General Counsel
9,304
0.0197%
$50.00$465,200-29.97%
2011-09-01SaleVertex Pharmaceuticals Incorporated
VRTX
SVP
328
0.0002%
$44.29$14,527-8.66%
Total: 16
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.